Alteration in dissolution characteristics of gelatin-containing formulations: A review of the problem, test methods, and solutions

Pharmaceutical Technology North America

Volumn 26, Issue 4, 2002, Pages 36-58

  Singh, Saranjit ^a   Rao, K V Rama ^a   Venugopal, K ^a   Manikandan, R ^a  

^a SAS Nagar   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DISSOLUTION; PROBLEM SOLVING; PROTEINS;

INFLUENCING FACTORS;

DRUG PRODUCTS;

ACROLEIN; ALANINE; ALDEHYDE; AMINO ACID; ARGININE; ASPARTIC ACID; CYSTEINE; CYSTINE; FORMALDEHYDE; FURFURAL; GELATIN; GLUTAMIC ACID; GLUTARALDEHYDE; GLYCERALDEHYDE; GLYCINE; HISTIDINE; HYDROXYPROLINE; IMINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TYROSINE; UNINDEXED DRUG; VALINE;

ARTICLE; DRUG CAPSULE; DRUG FORMULATION; DRUG SOLUBILITY; DRUG SOLUTION; MEDICAL LITERATURE;

EID: 0036334903     PISSN: 15342131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (91)

1. Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance
2. Effects of blending on the rheological properties of gelatin gels
3. Effect of gelatin properties in complex coacervation processes
4. Coating trends of solid dosage forms
5. Physical-mechanical properties of film-coated soft gelatin capsules
6. Physical and enteric properties of soft gelatin capsules coated with eudragit L30 D-55
7. In vitro release of theophyllin from cross-linked gelatin capsules
8. Oral solid dosage forms
9. Factors affecting zero-order release kinetics of porous gelatin capsules
10. Synthesis of gelatin microspheres containing interferon
11. Concentration of cross-linking agent as a tool for the control of release and swelling properties of gelatin microspheres
12. Gelatin microspheres cross-linked with D,L-Glyceraldehyde as a potential drug delivery system: Preparation, characterisation, in vitro and in vivo studies
13. Swelling behavior and mechanical properties of chemically cross-linked gelatin gels for biomedical use
14. Controlled gene delivery by DNA-gelatin nanospheres
15. The preparation of soft gelatin capsules for a radioactive tracer study
16. Adhesiveness of proprietary tablets and capsules to porcine esophageal tissue
17. Adherence of various oral dosage forms to the esophagus
18. Severe anaphylactoid reactions after infusion of modified gelatin solution
19. Pellicule formation in gelatin capsules
20. Effects of aging and relative humidity on drug release, Part 1: Chloramphenicol capsules
21. Effect of aging on physical properties of phenylbutazone tablets
22. Influence of a sugar coating on certain physical properties of series of core tablets
23. Dissolution of propantheline bromide tablets B.P
24. Variations in dissolution rates of sugar-coated chlorpromazine tablets
25. Effects of short-term moderate storage stress on the disintegration and dissolution of four types of compressed tablets
26. Dissolution testing of ibuprofen tablets
27. Effect of aging on dissolution rates and bioavailability of riboflavin sugar-coated tablets
28. The effect of pancreatin on the dissolution performance of gelatin-coated tablets exposed to high humidity conditions
29. Preparation and in vitro evaluation of powder solution tablets of valproic acid
30. Stability testing for gelatin-based formulations: Rapidly evaluating the possibility of a reduction in dissolution rates
31. Current perspectives on the dissolution stability of solid oral dosage forms
32. A study on gelatin capsule brittleness: Moisture transfer between the capsule shell and its content
33. Linearization of dissolution rate curves by the weibull distribution
34. The shelf life of some antibiotic preparations stored under tropical conditions
35. Investigation of drug biopharmaceutical stability: Application to capsules of tetracycline hydrochloride, Part 2: In vivo study
36. Effect of particle size, content in lubricant, mixing time, and storage relative humidity on drug release from hard gelatin capsules
37. Dissolution stability of hard-shell capsule products, part II: The effect of dissolution test conditions on in vitro drug release
38. Dissolution stability of hard-shell capsule products, part I: The effect of exaggerated storage conditions
39. The dissolution and bioavailability of etodolac from capsules exposed to conditions of high relative humidity and temperatures
40. Capsules: Soft gelatin capsules
41. Soft gelatin capsules: Solution to many tableting problems
42. Soft gelatin capsule update
43. The effects of cross-linking on the in vivo disintegration of hard gelatin capsules
44. Decrease in the rate of capsule dissolution due to formaldehyde from polysorbate 80 autooxidation
45. Dissolution testing of soft-shell capsules - Acetaminophen and nifedipine
46. Effect of scaling up and formulation factors on the qualities of prednisone tablets
47. The effects of storage upon in vitro and in vivo characteristics of soft gelatin capsules containing digoxin
48. Storage of phenytoin capsules
49. Investigation of drug biopharmaceutical stability, part 3: Study of ampicillin trihydrate capsules (in vitro-in vivo investigation)
50. Soft gelatin capsules I: Factors affecting capsule-shell dissolution rate
51. Disintegration test media for soft gelatin capsules - Need for global harmonization
52. Bioequivalence study of stressed and unstressed hard gelatin capsules using amoxycillin as a drug marker and gamma scintigraphy to confirm time and GI location of in vivo capsules rupture
53. The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules
54. Physical tests and determinations
55. Studies directed toward the development of enzymatic dissolution test methods for cross-linked hard gelatin capsule formulations containing poorly water-soluble drug substances
56. Shell-content interactions in gelatin capsules and a critical evaluation of their effects on drug availability
57. Cross-linking studies in gelatin capsules treated with formaldehyde and exposed to elevated temperature and humidity
58. Determination of extent of formaldehyde-induced cross-linking in hard gelatin capsules by near-infrared spectrophotometry
59. Detection of formaldehyde-induced cross-linking in soft elastic gelatin capsules using near-infrared spectrometry
60. Carbon 13-nuclear magnetic resonance studies on gelatin cross-linking by formaldehyde
61. Evaluation of gelatins for cross-linking potential
62. Rayon: Source of furfural - A reactive aldehyde capable of insolublizing gelatin capsules
63. Liquid and solid interactions of primary certified colorants with pharmaceutical gelatins
64. Hard gelatin capsules
65. Temperature-related incompatibility between gelatin and calcium carbonate in sugar-coated tablets
66. Effect of rayon coiler on the dissolution stability of hard-shell gelatin capsules
67. Effect of storage temperature on disintegration time of soft gelatin capsules
68. Effect of storage temperature on the physicochemical properties of soft gelatin capsule shells
69. Effect of formaldehyde on the physicochemical properties of soft gelatin capsule shells
70. Insolubility of gelatin films in systems simulating the subcoat of sugar-coated tablets
71. Investigation and evaluation of the utilization of gelatin treated with ionizing radiation in the pharmaceutical industry
72. Studies on the influence of ph and pancreatin on 13c-formaldehyde-induced gelatin crosslinks using nuclear magnetic resonance
73. 13C NMR study
74. 13C NMR spectroscopy
75. Cross-linking of gelatin in the reaction with formaldehyde: An FTIR spectroscopic study
76. The determination of ε-amino group in soluble and poorly soluble proteinaceous materials by a spectrophotometric method using trinitrobenzenesulfonic acid
77. Chemical and swelling evaluations of amino group cross-linking in gelatin and modified gelatin matrices
78. Intrinsic fluorescence investigation on the change in conformation of cross-linked gelatin gel during volume phase transition
79. Examination of self-cross-linked gelatin as a hydrogel for controlled release
80. Microencapsulation par reticulation interfaciale de gelaitine
81. A phenomenon of gelatin insolubility
82. Effect of glycine-citric acid on the dissolution stability of hard gelatin capsules
83. The influence of disintegrant level and capsule size on dissolution of hard gelatin capsules stored in high-humidity conditions
84. Photodecomposition and stabilization of compounds in dosage forms
85. Phenytoin I: In vitro-in vivo correlation for 100 mg phenytoin sodium capsules
86. Effect of storage on nitrofurantoin solid dosage forms
87. Soft gelatin capsules III: An accelerated method for evaluating the dissolution stability of various gel formulations